Personalis, Inc. Contracts & Agreements

Amendment No. 2 to the Commercialization and Reference Laboratory Agreement, dated September 20, 2024, by and between Personalis, Inc. and Tempus AI, Inc (Filed With SEC on November 6, 2024)

Investment Agreement, dated August 16, 2024, by and between Personalis, Inc. and Tempus AI, Inc (Filed With SEC on August 16, 2024)

Amendment No. 1 to the Commercialization and Reference Laboratory Agreement, dated August 16, 2024, by and between Personalis, Inc. and Tempus AI, Inc (Filed With SEC on August 16, 2024)

Settlement and License Agreement, between Personalis, Inc. and Foresight Diagnostics, Inc., dated June 21, 2024 (Filed With SEC on June 27, 2024)

Amended and Restated Non-Employee Director Compensation Policy, dated February 27, 2024 (Filed With SEC on May 8, 2024)

Personalis, Inc. 2020 Inducement Plan, as amended (Filed With SEC on February 28, 2024)

Form of RSU Award Agreement under 2020 Inducement Plan (Filed With SEC on February 28, 2024)

Form of Option Agreement under 2020 Inducement Plan (Filed With SEC on February 28, 2024)

Second Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Christopher Hall (Filed With SEC on February 28, 2024)

Third Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Aaron Tachibana (Filed With SEC on February 28, 2024)

Third Amended and Restated Executive Severance Agreement, dated September 25, 2023, between the Company and Richard Chen (Filed With SEC on February 28, 2024)

Second Amended and Restated Executive Severance Agreement, dated September 18, 2023, between the Company and Stephen Moore (Filed With SEC on February 28, 2024)

Warrant to Purchase Shares of Common Stock of Personalis, Inc., dated November 28, 2023, and expiring December 31, 2024 (the First Warrant) (Filed With SEC on November 28, 2023)

Warrant to Purchase Shares of Common Stock of Personalis, Inc., dated November 28, 2023, and expiring December 31, 2025 (the Second Warrant) (Filed With SEC on November 28, 2023)

Commercialization and Reference Laboratory Agreement, between Personalis, Inc. and Tempus Labs, Inc., dated November 25, 2023 (Filed With SEC on November 28, 2023)

Amended and Restated Employment Agreement dated March 7, 2023, between the Company and Aaron Tachibana (Filed With SEC on March 8, 2023)

Amended and Restated Offer Letter, dated March 7, 2023, between the Company and Christopher Hall (Filed With SEC on March 8, 2023)

Amended and Restated Employment Agreement dated March 8, 2023, between the Company and Richard Chen (Filed With SEC on March 8, 2023)

Second Amended and Restated Executive Severance Agreement, dated March 7, 2023, between the Company and Aaron Tachibana (Filed With SEC on March 8, 2023)

First Amended and Restated Executive Severance Agreement, dated March 7, 2023, between the Company and Christopher Hall (Filed With SEC on March 8, 2023)

Second Amended and Restated Executive Severance Agreement, dated March 8, 2023, between the Company and Richard Chen (Filed With SEC on March 8, 2023)

Separation Agreement, dated December 14, 2022, between the Company and John West (Filed With SEC on December 14, 2022)

Contract No. 36C24E22D0031, by and between the U.S. Department of Veterans Affairs and the Registrant, dated September 30, 2022 (Filed With SEC on November 2, 2022)

Amendment No. 2 to Lease, by and between Ardenwood Ventures I, LLC and the Registrant, dated June 9, 2022 (Filed With SEC on August 3, 2022)

Amendment No. 1 to Lease, by and between Ardenwood Ventures I, LLC and the Registrant, dated December 8, 2021 (Filed With SEC on February 24, 2022)

Amended Personalis, Inc. Non-Employee Director Compensation Policy, dated February 17, 2022 (Filed With SEC on February 24, 2022)

Amended and Restated Executive Severance Agreement, by and between John West and the Registrant, dated February 23, 2022 (Filed With SEC on February 24, 2022)

Amended and Restated Executive Severance Agreement, by and between Dr. Richard Chen and the Registrant, dated February 23, 2022 (Filed With SEC on February 24, 2022)

Amended and Restated Executive Severance Agreement, by and between Aaron Tachibana and the Registrant, dated February 23, 2022 (Filed With SEC on February 24, 2022)

At-the-Market Sales Agreement, dated December 30, 2021, by and between Personalis, Inc. and BTIG, LLC (Filed With SEC on January 3, 2022)

Lease, by and between Ardenwood Ventures I, LLC and the Registrant, dated August 25, 2021 (Filed With SEC on November 4, 2021)

Description of Securities of Personalis, Inc (Filed With SEC on February 25, 2021)

Personalis, Inc. Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2021)

Underwriting Agreement, dated January 26, 2021, by and among the Company, Morgan Stanley & Co. LLC, BofA Securities, Inc., Citigroup Global Markets Inc., and Cowen and Company,... (Filed With SEC on January 27, 2021)

Underwriting Agreement, dated August 11, 2020, by and among the Company, BofA Securities, Inc., Citigroup Global Markets Inc., and Cowen and Company, LLC, as representatives of... (Filed With SEC on August 12, 2020)

First Amendment to Lease, by and between MENLO PREPI I, LLC and TPI INVESTORS 9, LLC and the Registrant, dated April 8, 2020 (Filed With SEC on August 6, 2020)

Amendment to Employment Terms Letter, by and between John West and the Registrant, dated May 6, 2020 (Filed With SEC on May 7, 2020)

Description of Securities of Personalis, Inc (Filed With SEC on March 25, 2020)

Quotation for Supply of Genetic Analysis Products, by and between Illumina, Inc. and the Registrant, dated November 19, 2019 (Filed With SEC on March 25, 2020)

Form of Underwriting Agreement (Filed With SEC on June 7, 2019)

Form of common stock certificate of the Registrant (Filed With SEC on June 7, 2019)

Personalis, Inc. 2019 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on June 7, 2019)

Personalis, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on June 7, 2019)

Form of Indemnification Agreement entered into by and between the Registrant and each director and executive officer (Filed With SEC on June 7, 2019)

Employment Terms Letter, by and between John West and the Registrant, dated June 2, 2019 (Filed With SEC on June 7, 2019)

Employment Terms Letter, by and between Clinton Musil and the Registrant, dated June 2, 2019 (Filed With SEC on June 7, 2019)

Employment Terms Letter, by and between Dr. Richard Chen and the Registrant, dated June 2, 2019 (Filed With SEC on June 7, 2019)

Employment Terms Letter, by and between Aaron Tachibana and the Registrant, dated June 2, 2019 (Filed With SEC on June 7, 2019)

Amended and Restated Investor Rights Agreement by and among the Registrant and certain of its stockholders, dated December 16, 2014 (Filed With SEC on May 23, 2019)

Warrant to purchase capital stock of the Registrant, issued to Silicon Valley Bank, dated September 25, 2014 (Filed With SEC on May 23, 2019)

Warrant to purchase capital stock of the Registrant, issued to TriplePoint Capital LLC, dated June 28, 2017 (Filed With SEC on May 23, 2019)

Warrant to purchase capital stock of the Registrant, issued to TriplePoint Capital LLC, dated March 22, 2019 (Filed With SEC on May 23, 2019)

Personalis, Inc. 2011 Equity Incentive Plan, as amended, and forms of agreements thereunder (Filed With SEC on May 23, 2019)

Lease, by and between MENLO PREHC I, LLC, MENLO PREPI I, LLC, TPI Investors 9, LLC and the Registrant, dated February 2, 2015 (Filed With SEC on May 23, 2019)

Contract No. VA240-17-D-0103, by and between the U.S. Department of Veterans Affairs and the Registrant, dated September 28, 2017 (Filed With SEC on May 23, 2019)

Quotation for Supply of Genetic Analysis Products No. 4079884, by and between Illumina, Inc. and the Registrant, dated March 21, 2017 (Filed With SEC on May 23, 2019)

Purchase Order No. P11405, by and between Illumina, Inc. and the Registrant, dated March 31, 2017 (Filed With SEC on May 23, 2019)

Master Services Subcontract Agreement, by and between Illumina, Inc. and the Registrant, dated November 1, 2017 (Filed With SEC on May 23, 2019)

Pricing Agreement, by and between Illumina, Inc. and the Registrant, dated November 22, 2017 (Filed With SEC on May 23, 2019)

Fasttrack Genetic Analysis Services Agreement No. MQ-20171213CG100, by and between Illumina, Inc. and the Registrant, dated December 13, 2017 (Filed With SEC on May 23, 2019)

Quotation for Supply of Genetic Analysis Products No. SQ-20190214CG102, by and between Illumina, Inc. and the Registrant, dated February 22, 2019 (Filed With SEC on May 23, 2019)

Quotation for Supply of Genetic Analysis Products No. 4192031, by and between Illumina, Inc. and the Registrant, dated March 1, 2019 (Filed With SEC on May 23, 2019)

Purchase Order No. P11405, by and between Illumina, Inc. and the Registrant, dated March 20, 2019 (Filed With SEC on May 23, 2019)

Pricing Agreement, by and between Illumina, Inc. and the Registrant, dated March 26, 2019 (Filed With SEC on May 23, 2019)

Plain English Revolving Loan and Security Agreement, by and between TriplePoint Capital LLC and the Registrant, dated June 28, 2017 (Filed With SEC on May 23, 2019)

First Amendment to Plain English Revolving Loan and Security Agreement, by and between TriplePoint Capital LLC and the Registrant, dated March 22, 2019 (Filed With SEC on May 23, 2019)

Form of convertible promissory note of the Registrant (Filed With SEC on May 23, 2019)

Amendment No. 1 to the convertible promissory note of the Registrant (Filed With SEC on May 23, 2019)

Amendment No. 2 to the convertible promissory note of the Registrant (Filed With SEC on May 23, 2019)

Category

Industry

Companies

Contracts

Personalis, Inc. Contracts & Agreements